Home » Topics » BioWorld Science

BioWorld Science
RSS

New TNF-alpha inhibitors reported by Celgene

Sep. 13, 1996

Vasopressin antagonists from American Cyanamid

Sep. 13, 1996

Mitsui Toatsu claims long-acting oral form of MS-551

Sep. 13, 1996

Pharmacia & Upjohn discloses class III antiarrhythmic agents

Sep. 13, 1996

Antiarrhythmic peptides claimed by BASF

Sep. 13, 1996

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Inhibitors of ceramide-mediated signal transduction

Sep. 13, 1996

Researchers isolate sodium pump inhibitor from human placenta

Sep. 13, 1996

IVAX receives approval for generic antihypertensive drug

Sep. 13, 1996

Warner-Lambert focuses on endothelin antagonists

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026